 Antihypertensive Agents
"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
| Descriptor ID |
D000959
|
| MeSH Number(s) |
D27.505.954.411.162
|
| Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 2 | 0 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 3 | 6 | | 2001 | 3 | 2 | 5 | | 2002 | 6 | 2 | 8 | | 2003 | 5 | 1 | 6 | | 2004 | 5 | 1 | 6 | | 2005 | 7 | 5 | 12 | | 2006 | 9 | 3 | 12 | | 2007 | 4 | 2 | 6 | | 2008 | 6 | 5 | 11 | | 2009 | 7 | 8 | 15 | | 2010 | 13 | 13 | 26 | | 2011 | 13 | 7 | 20 | | 2012 | 14 | 6 | 20 | | 2013 | 11 | 7 | 18 | | 2014 | 16 | 7 | 23 | | 2015 | 16 | 4 | 20 | | 2016 | 9 | 12 | 21 | | 2017 | 7 | 8 | 15 | | 2018 | 12 | 9 | 21 | | 2019 | 11 | 6 | 17 | | 2020 | 9 | 3 | 12 | | 2021 | 8 | 4 | 12 | | 2022 | 5 | 7 | 12 | | 2023 | 6 | 10 | 16 | | 2024 | 16 | 6 | 22 | | 2025 | 9 | 1 | 10 | | 2026 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Denburg MR, Goodwin Davies AJ, Maltenfort MG, Mitsnefes MM, Flynn JT, Neu AM, Dixon BP, Glenn DA, Gluck CA, Harshman LA, Katsoufis CP, Leonard MB, Modi ZJ, Pan CG, Patel HP, Patterson LT, Verghese PS, Wilson AC, Jovanovska A, Levondosky R, Levondosky M, Dickinson K, Wieand K, Razzaghi H, Li L, Chen Y, Forrest CB. Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease. JAMA Pediatr. 2026 May 01; 180(5):546-555.
-
Daley MF, Rifas-Shiman SL, Young JG, Petimar J, Prentice C, Bailey LC, Janicke DM, Heerman WJ, Block JP. Effects of Common Antihypertensive Class Medications on BMI z-Score in Adolescents. Pediatr Obes. 2026 May; 21(5):e70114.
-
Zheutlin AR, Chaitoff A, Addo D, Jacobs JA, Derington CG, Stulberg EL, Glynn PA, Modenesi B, Cohen JB, Bress AP. Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment. J Am Heart Assoc. 2026 Apr 21; 15(8):e047792.
-
Sanuade OA, Addo DK, Smith JD, Carroll AJ, Shimbo D, Talegawkar S, Tucker KL, Jacobs JA, Derington CG, Bress AP. The association of urinary sodium with incident apparent treatment resistant hypertension among African Americans: findings from the Jackson Heart Study. J Hum Hypertens. 2026 May; 40(5):405-412.
-
Singh A, Singh MP, Thakur P, Khasbage SU, Yadav R. Efficacy of pharmacological agents for management of post-partum hypertension: A systematic review and network meta-analysis. J Hum Hypertens. 2026 Mar; 40(3):147-157.
-
Scarton L, Nelson T, Yao Y, Branam D, Podany C, Legaspi AB, Aguila M, Orozco D, Almutairi A, Rabie A, Jiao T, Jo A, Donahoo WT, Segal R, Goins RT, Manson SM, Wilkie DJ. Relationships Between Antihypertensive, Glucose- and Lipid-Lowering Medication Adherence, and Demographic and Clinical Characteristics in American Indian Adults With Type 2 Diabetes. J Diabetes Res. 2026; 2026(1):e5960974.
-
Billups SJ, Daffron A, Harty C, Schilling LM, Lowe RN, Lobo I. Centralized outreach with embedded pharmacist e-consultation to reduce therapeutic inertia and improve blood pressure control. Am J Health Syst Pharm. 2025 Nov 07; 82(22):1249-1255.
-
Derington CG, Berchie RO, Greene T, Jacobs JA, Moran AE, Xu Y, Narita K, Zheutlin AR, Cohen JB, Shimbo D, Bress AP. Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT. J Am Coll Cardiol. 2025 Oct 28; 86(17):1437-1448.
-
Lin PD, Rifas-Shiman SL, Petimar J, Yu H, Daley MF, Janicke DM, Heerman WJ, Bailey LC, Maeztu C, Lewis KH, Young JG, Block JP. Emulation of a Target Trial of Antihypertensive Medications on Weight Change. J Gen Intern Med. 2026 03; 41(4):1097-1106.
-
Pantcheva MB, Gangaputra S, Sieck E, Accorinti M, Neumann R, Ang BCH, Barton K, Chu DS, Grigg J, Kempen JH, Liebmann JM, Muñoz-Negrete FJ, Nguyen QD, Palestine AG, Thorne J, van Meerwijk C, Yang P, de Smet MD. Uveitic Glaucoma Interest Group Recommendations for Uveitis-Related Ocular Hypertension and Glaucoma Management. Ocul Immunol Inflamm. 2025 Nov; 33(9):2153-2167.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|